UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017867
Receipt number R000020699
Scientific Title Consideration of cardiac function improvement effect of Omega-3 fatty acids(EPA +DHA)
Date of disclosure of the study information 2015/07/01
Last modified on 2015/06/10 20:11:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Consideration of cardiac function improvement effect of Omega-3 fatty acids(EPA +DHA)

Acronym

Consideration of cardiac function improvement effect of Omega-3 fatty acids(EPA +DHA)

Scientific Title

Consideration of cardiac function improvement effect of Omega-3 fatty acids(EPA +DHA)

Scientific Title:Acronym

Consideration of cardiac function improvement effect of Omega-3 fatty acids(EPA +DHA)

Region

Japan


Condition

Condition

Chronic heart failure patient with dyslipidemia

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

For chronic heart failure patients which merge dyslipidemia, consider a cardiac function improving effect by administering an Omega-3 fatty acids

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

LVEF, E/e', NTproBNP at 0, 6months after starting of treatment

Key secondary outcomes

TG,High sensitivity CRP, Quadrant blood fatty acid(EPA/AA)


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Omega-3 fatty acid administration

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

1.Chronic heart failure of LVEF >=40% of non-ischemic cardiomyopathy
2.EPA/AA ratio is less than 0.5 of dyslipidemia
3.Patient who is competent to understand the aim of this study and agree on it

Key exclusion criteria

1. Patients who are bleeding
2. Past medical history of hypersensitivity 3. Judged as ineligible by physicians

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Konomi Sakata

Organization

Kyorin University School of Medicine

Division name

Second Department of Internal Medicine

Zip code


Address

86-20-2 Shinkawa Mitaka Tokyo 181-8611 JAPAN

TEL

0422-47-5511

Email

sakata@ks.kyorin-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Konomi Sakata

Organization

Kyorin University School of Medicine

Division name

Second Department of Internal Medicine

Zip code


Address

6-20-2 Shinkawa Mitaka Tokyo 181-8611 JAPAN

TEL

0422-47-5511

Homepage URL


Email

sakata@ks.kyorin-u.ac.jp


Sponsor or person

Institute

Kyorin University School of Medicine, Second department of Internal Medicine

Institute

Department

Personal name



Funding Source

Organization

Kyorin University School of Medicine, Second department of Internal Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2015 Year 05 Month 18 Day

Date of IRB


Anticipated trial start date

2015 Year 07 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 06 Month 10 Day

Last modified on

2015 Year 06 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020699


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name